Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

Bone Marrow Transplantation, Published online: 06 February 2024; doi:10.1038/s41409-024-02228-zCost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

Source: Bone Marrow Transplantation - February 6, 2024 Category: Hematology Authors: P. Ahmadi S. Ghandili F. Jakobs C. Konnopka A. Morgner-Miehlke N. Kr öger F. Ayuk Source Type: research